^
Association details:
Biomarker:No biomarker
Cancer:Endometrial Cancer
Drug:fulvestrant (Selective estrogen receptor degrader)
Direction:Sensitive
Evidence:
Evidence Level:
Sensitive: A2 - Guideline
New
Source:
Excerpt:
Endometrial cancer: Systemic Therapy for Endometrial Carcinoma...Recurrent, Metastatic or High-risk Diseaseā€¦Preferred regimensā€¦Fulvestrant